Clinical Trials List
2020-03-15 - 2025-05-15
Phase III
Terminated3
ICD-10H35.89
Other specified retinal disorders
ICD-9362.89
Other retinal disorders
An extension study to evaluate the long-term outcomes of subjects who received treatment for retinopathy of prematurity in Study 20090
-
Trial Applicant
BAYER TAIWAN COMPANY LTD.
-
Sponsor
Bayer AG.
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Yih-Shiou Hwang 無
- 江明洲 無
- 傅仁煇 無
- Yu-Shu Huang 無
- 陳冠任 無
- 陳彥伯 無
- 林瑞瑩 無
- 劉珍吟 無
- Jen Fu Hsu 無
- 朱世明 無
- Chun-Hsiu Liu 無
- 孫銘輝 無
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Hsiu-Lin Chen Division of Ophthalmology
- Li-chung Chi Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Completed
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Proportion of subjects with ocular AEs and SAEs
Proportion of subjects with systemic AEs and SAEs
Inclution Criteria
- Subject was treated in Study 20090
- Age less than 13 months of chronological age
- Signed informed consent from parent(s)/legally authorized representative(s), which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in this protocol
Exclusion Criteria
- Subject has a condition preventing participation in the study, or performance of study procedures.
The Estimated Number of Participants
-
Taiwan
3 participants
-
Global
100 participants
